Related Experiment Video
Updated: Aug 19, 2025

The Use of Mouse Mammary Tumor Cells in an In Vitro Invasion Assay as a Measure of Oncogenic Cell Behavior
Published on: June 12, 2019
Long noncoding RNA MEG3 inhibits oral squamous cell carcinoma progression via GATA3
1Department of Stomatology, Affiliated Hospital of Hebei University, Baoding, China.
Abstract:
Oral squamous cell carcinoma (OSCC) accounts for about 90% of oral cancers. Expression of the long noncoding RNA (lncRNA) maternally expressed 3 (MEG3) has previously been reported to be downregulated in OSCC, and its overexpression can inhibit proliferation, migration, and invasion and promote apoptosis of OSCC cells. However, the mechanism underlying MEG3 downregulation in OSCC has not been well characterized. Here we report that low expression of MEG3 is caused by H3K27me3 modification of the MEG3 gene locus, and this is associated with the poor prognosis of OSCC. Overexpression of MEG3 inhibited the proliferation and invasion of OSCC cells. We observed that MEG3 was modified by m6A and bound to YTHDC1. Enhancer-controlled genes positively regulated by MEG3 were functionally enriched for the 'negative regulation of Wnt signaling pathway' term, as determined using metascape. GATA3 was predicted to be a transcription factor for these genes, and was demonstrated to bind to MEG3. Knockdown of GATA3 countered the effects on proliferation, invasion, and increased transcription of HIC1 and PRICKLE1 induced by MEG3 overexpression. In conclusion, our data suggest that MEG3 is downregulated in OSCC due to trimethylation of H3K27 at the MEG3 gene locus. The inhibitory effect of MEG3 on proliferation and invasion of OSCC cells was dependent on the binding of GATA3.
Insights
Maternally expressed 3 (MEG3) long noncoding RNA is downregulated in oral cancer due to H3K27me3 modification. MEG3 inhibits oral squamous cell carcinoma progression by interacting with GATA3.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent cancer.
- Maternally expressed 3 (MEG3) long noncoding RNA (lncRNA) is downregulated in OSCC.
- The mechanism of MEG3 downregulation in OSCC remains unclear.
Purpose of the Study:
- Investigate the mechanism of MEG3 downregulation in OSCC.
- Elucidate the role of MEG3 in OSCC progression.
- Identify MEG3-interacting proteins and pathways.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) to assess H3K27me3 modification.
- Quantitative real-time PCR (qRT-PCR) to measure gene expression.
- Western blotting to detect protein levels.
- RNA immunoprecipitation (RIP) assay to confirm RNA-protein interactions.
- Functional assays (proliferation, invasion) to evaluate MEG3's role.
Main Results:
- MEG3 downregulation in OSCC is caused by H3K27 trimethylation (H3K27me3) at the MEG3 gene locus.
- Overexpression of MEG3 inhibits OSCC cell proliferation and invasion.
- MEG3 interacts with YTHDC1 and GATA3.
- MEG3 regulates enhancer-controlled genes involved in the Wnt signaling pathway.
- GATA3 mediates the inhibitory effects of MEG3 on OSCC progression.
Conclusions:
- MEG3 downregulation in OSCC is epigenetically regulated by H3K27me3.
- MEG3 functions as a tumor suppressor in OSCC.
- The MEG3-GATA3 axis plays a critical role in regulating OSCC cell proliferation and invasion.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Abnormal Proliferation
Types of RNA
RNA Performs Diverse...